Cancer Research

Let The Love Last Longer This February With Clinique And The KISS IT BETTER Appeal At House Of Fraser.

LONDON, January 25 /PRNewswire/-- Clinique is delighted to announce its partnership with Great Ormond Street Hospital for the KISS IT BETTER appeal- to raise money to fund research into the causes and treatment of childhood cancer. KISS IT BETTER is the b ...

Article - Anna Ohlden - Jan 25 2008 - 4:30am

Adult Stem Cells May Help Repair Bone

The use of a drug to activate stem cells that differentiate into bone appears to cause regeneration of bone tissue and be may be a potential treatment strategy for osteoporosis, according to a report in the February 2008 Journal of Clinical Investigation. ...

Article - News Staff - Jan 25 2008 - 11:18am

Clexane(R)/Lovenox(R) Approved In Japan

PARIS, January 28 /PRNewswire/-- Sanofi-aventis announced today that the anticoagulant Clexane(R) (enoxaparin sodium injection) has been approved for marketing in Japan by the Ministry of Health, Labour and Welfare for the prevention of venous thromboembo ...

Article - Anna Ohlden - Jan 28 2008 - 2:30am

Valentine's Day: Clinique At Harrods Donates All Takings To The KISS IT BETTER Appeal

LONDON, January 28 /PRNewswire/-- On Valentine's Day 1852 Great Ormond Street Hospital opened its doors for the first time. In honour of the hospital's birthday Clinique and Harrods have joined forces to raise funds for Great Ormond Street Hospi ...

Article - Anna Ohlden - Jan 28 2008 - 4:30am

Novartis CIO Joins Smart Lab Laboratory Informatics Exchange

LONDON, January 28 /PRNewswire/-- Dean Flanders, CIO of the Novartis Research Foundation, Graham Watson, CTO at Cancer Research Technology and Martin Blueggel, COO at Protagen are among the thirty plus industry leaders presenting at the Smart Lab Exchange ...

Article - Anna Ohlden - Jan 28 2008 - 7:31am

90% Gone In Some Areas: How To Save Tasmanian Devils?

A unique transmissible and rapidly spreading cancer threatens the very existence of Tasmanian devils. To combat this particularly aggressive disease, a Cold Spring Harbor Laboratory research team, in collaboration with 454 Lifesciences, is committing resou ...

Article - News Staff - Jan 28 2008 - 5:33pm

Viventia Biotech To Explore Strategic Alternatives- Reports Positive Pivotal Phase III Interim Efficacy Data

TORONTO, January 29 /PRNewswire/-- Viventia Biotech Inc., a privately held biopharmaceutical company advancing a portfolio of novel antibody therapeutics focused on cancer, announced today it intends to explore strategic alternatives to further advance an ...

Article - Anna Ohlden - Jan 29 2008 - 7:30am

How Ancient Viral Infections Insured Healthier Pregnancies Today

Sequences of DNA in the human genome that originated from ancient viral infections have some surprising effects on our bodies and are even essential for a healthy pregnancy, according to an article in the February issue of Microbiology Today. Retrovirus in ...

Article - News Staff - Jan 29 2008 - 10:22am

Genetic Lab-In-A-Shoebox Will Make Testing Portable And Cheap

University of Alberta researchers in Edmonton, Canada, have developed a portable unit for genetic testing about the size of a shoebox, which has the same capability as a lab full of expensive equipment. The device – along with other, even smaller units the ...

Article - News Staff - Jan 29 2008 - 11:09am

Forensics: Researchers Can Now Determine Birthdate... Through Proteins In The Eye

Researchers at the University of Copenhagen and Aarhus have shown they are able to use the radiocarbon dating method to study special proteins in the lens of the eye- they use a nuclear accelerator to determine the amount of Carbon-14 in as little as one m ...

Article - News Staff - Jan 31 2008 - 3:06am